We deliver high-quality solutions to assess translational control of gene expression and translatome-associated biomarkers.
The Ribosome Company
Immagina BioTechnology has developed RiboLace™, an antibody-free technology for the analysis of biologically relevant macromolecules by selectively isolating native and active polyribosomes. RiboLace™ is the first technology to capture only the active fraction of mRNA being translated, which is the actual measure of which proteins are being produced. RiboLace™ provides a snapshot of protein expression for an accurate picture of what a cell is manufacturing and insights into its pathological state.
Immagina’s ambition is to deliver smart solutions for truer gene expression analysis in research and hospital labs, to support life science worldwide.
We are working to provide you with the best picture of gene expression.
Because the message is only part of the story.
Wants to join the startup company to help accomplish our mission?